Skip to main content

Find Clinical Trials

Home
Conditions
Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Clinical trial condition

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Explore clinical trials studying Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer trial results

Completed

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

NCT00154102

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Research Site Buenos Aires, Argentina

Research Site Bedford Park, Australia

Research Site Darlinghurst, Australia

Research Site Heidelberg, Australia

View all 154 locations

View Trial Details